If you're an overweight or obese adult without diabetes, taking GLP-1 drugs like Ozempic might lower your chances of having a heart attack by about 27% compared to taking a fake pill.

65

Pro

0

Against

Evidence from Studies

Supporting (1)

65

Community contributions welcome

65

Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis

Systematic Review With Meta-Analysis

Human

2024

The study looked at whether GLP-1 drugs lower heart problem risks in overweight people without diabetes, and found they do. While it didn’t look only at heart attacks, it supports the idea these drugs help protect the heart.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis

Score: 65

DOI: 10.3389/fcvm.2024.1453297

Similar Assertions

If you're an overweight or obese adult without diabetes, taking GLP-1 drugs like those used for weight loss might lower your chances of needing heart artery procedures by about 22%.

65

0

89%

If you're overweight or obese but don't have diabetes, taking GLP-1 drugs like Ozempic can lower your chances of having heart problems by about 1 in 4 compared to not taking them.

65

0

88%

Taking GLP-1 drugs like Ozempic doesn’t seem to lower the chance of having a stroke for people who are overweight or obese but don’t have diabetes, at least compared to taking a dummy pill.

0

65

86%

Some diabetes drugs like liraglutide, semaglutide, and dulaglutide may help protect the heart and lower the chance of serious heart problems in people with type 2 diabetes who already have heart disease — and this benefit might not just be because they lower blood sugar.

1

0

84%

GLP-1 drugs shrink a layer of fat that surrounds the heart — this fat is linked to heart disease, and shrinking it may help protect the heart from damage.

0

1

81%